CDC42:,,

Mingchao Chen1, Kai Gao1, Zijiang Guo1

  • 1Department of Intensive Care Unit, Affiliated Hospital of Hebei University of Engineering, Handan, China.

概括

败血症患者的细胞分裂周期42 (CDC42) 降低水平与器官功能障碍和死亡风险增加相关. 疾病预防控制中心42显示潜在的预后生物标志物对于败血症的严重程度和结果.